A detailed history of Jpmorgan Chase & CO transactions in Olink Holding Ab (Publ) stock. As of the latest transaction made, Jpmorgan Chase & CO holds 363,485 shares of OLK stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
363,485
Previous 313,913 15.79%
Holding current value
$0
Previous $7.38 Million 25.49%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$21.87 - $25.59 $1.08 Million - $1.27 Million
49,572 Added 15.79%
363,485 $9.26 Million
Q1 2024

May 10, 2024

BUY
$21.81 - $25.14 $6.85 Million - $7.89 Million
313,913 New
313,913 $7.38 Million

Others Institutions Holding OLK

About Olink Holding AB (publ)


  • Ticker OLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 119,098,000
  • Description
  • Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...
More about OLK
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.